Epigenetic modifications and human disease.
Portela A, Esteller M.
Nat Biotechnol. 2010 Oct;28(10):1057-68. doi: 10.1038/nbt.1685.
Pallidal degenerations and related disorders: an update.
Jellinger KA.
J Neural Transm (Vienna). 2022 Jun;129(5-6):521-543. doi: 10.1007/s00702-021-02392-2. Epub 2021 Aug 7.
Secondary dystonia.
Calne DB, Lang AE.
Adv Neurol. 1988;50:9-33.
tRNA modifications regulate translation during cellular stress.
Gu C, Begley TJ, Dedon PC.
FEBS Lett. 2014 Nov 28;588(23):4287-96. doi: 10.1016/j.febslet.2014.09.038. Epub 2014 Oct 7.
[Oxidative stress in human diseases].
Favier A.
Ann Pharm Fr. 2006 Nov;64(6):390-6. doi: 10.1016/s0003-4509(06)75334-2.
Endothelin-1-induced endoplasmic reticulum stress in disease.
Jain A.
J Pharmacol Exp Ther. 2013 Aug;346(2):163-72. doi: 10.1124/jpet.113.205567. Epub 2013 Jun 5.
Iatrogenic Flatback and Flatback Syndrome: Evaluation, Management, and Prevention.
Boody BS, Rosenthal BD, Jenkins TJ, Patel AA, Savage JW, Hsu WK.
Clin Spine Surg. 2017 May;30(4):142-149. doi: 10.1097/BSD.0000000000000522.
Macular degeneration.
HAGENS W.
Am J Ophthalmol. 1953 Dec;36(12):1747-8; discussion, 1748.
Chorioretinal heredo-degeneration.
FRANCOIS J.
Proc R Soc Med. 1961 Dec;54(12):1109-15.
Clinical features of the congenital vitreoretinopathies.
Edwards AO.
Eye (Lond). 2008 Oct;22(10):1233-42. doi: 10.1038/eye.2008.38. Epub 2008 Feb 29.
